Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: Optical coherence tomographic analysis

JACC: Cardiovascular Interventions

Volumn 3, Issue 10, 2010, Pages 1074-1079

  Tanaka, Nobuyoshi ^a   Terashima, Mitsuyasu ^a   Rathore, Sudhir ^a   Itoh, Tsuyoshi ^a   Habara, Maoto ^a   Nasu, Kenya ^a   Kimura, Masashi ^a   Itoh, Tatsuya ^a   Kinoshita, Yoshihisa ^a   Ehara, Mariko ^a   Tsuchikane, Etsuo ^a   Asakura, Keiko ^a   Asakura, Yasushi ^a   Katoh, Osamu ^a   Suzuki, Takahiko ^a  

^a Toyohashi Heart Center Toyohashi   (Japan)

Author keywords

diabetes mellitus; optical coherence tomography; sirolimus eluting stent(s); vascular response

Indexed keywords

RAPAMYCIN;

AGED; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIROLIMUS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TUNICA INTIMA;

EID: 77958552788     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.08.006     Document Type: Article

References (19)

1. M.C. Morice, P.W. Serruys, J.E. Sousa RAVEL Study Group A randomized comparison of sirolimus-eluting stent with a standard stent for coronary revascularization N Engle J Med 346 2002 1773 1780
2. J.W. Moses, M.B. Leon, J.J. Popma SIRIUS Investigators Sirolimus eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
3. A. Jeremias, B. Sylvia, and J. Bridges Stent thrombosis after successful sirolimus eluting stent implantation Circulation 109 2004 1930 1932
4. P.A. Lemos, A. Hoye, and D. Goedhart Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) study Circulation 109 2004 1366 1370
5. O. Frbert, B. Lagerqvist, J. Carlsson, J. Lindbck, U. Stenestrand, and S.K. James Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry) J Am Coll Cardiol 53 2009 1660 1667
6. J. Machecourt, N. Danchin, J.M. Lablanche EVASTENT Investigators Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry J Am Coll Cardiol 50 2007 501 508
7. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
8. H. Katoh, J. Shite, and T. Shinke Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography Circ J 73 2009 1033 1037
9. P. Moore, P. Barlis, and J. Spiro A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents J Am Coll Cardiol Intv 5 2009 437 444
10. D. Matsumoto, J. Shite, and T. Shinke Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography Eur Heart J 28 2007 961 967
11. R. Kornowski, G.S. Mintz, and K.M. Kent Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia A serial intravascular ultrasound study Circulation 95 1997 1366 1369
12. I. Moussa, M.B. Leon, and D.S. Baim Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy Circulation 109 2004 2273 2278
13. P. Jimnez-Quevedo, M. Sabat, D.J. Angiolillo DIABETES Investigators Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) trial J Am Coll Cardiol 47 2006 2172 2179
14. C. Patterson, S. Mapera, and H.H. Li Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival: role of AKT-dependent signaling Arterioscler Thromb Vasc Biol 26 2006 1473 1480
15. D. Aranson, Z. Bloomgarden, and E.J. Rayfield Potential mechanisms promoting restenosis in diabetic patients J Am Coll Cardiol 27 1996 528 535
16. T. Kanazaki, M. Shinomiya, S. Ueda, N. Morizaki, Y. Saito, and S. Yoshida Enhanced arterial intimal thickening after balloon catheter injury in diabetic animals accompanied by PDGF β receptor overexpression Eur J Clin Invest 24 1994 377 381
17. M. Kirstein, J. Brett, S. Radoff, S. Ogawa, D. Stern, and H. Vlassara Advanced protein glycosylation induces selective transendothelial human monocyte chemotaxis and secretion of PDGF: role in vascular disease in diabetes and aging Proc Natl Acad Sci U S A 87 1990 9010 9014
18. M. Takano, M. Yamamoto, and S. Inami Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography J Am Coll Cardiol 55 2009 26 32
19. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202